These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 34576042)

  • 1. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
    Chou MY; Yang MH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
    Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
    Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.
    Romeo E; Caserta CA; Rumio C; Marcucci F
    Cells; 2019 May; 8(5):. PubMed ID: 31096701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted role of mesenchymal stem cells in cancer.
    Timaner M; Tsai KK; Shaked Y
    Semin Cancer Biol; 2020 Feb; 60():225-237. PubMed ID: 31212021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
    Dominguez C; David JM; Palena C
    Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis.
    Baj J; Brzozowska K; Forma A; Maani A; Sitarz E; Portincasa P
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
    Jiang Y; Zhan H
    Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.
    Romano S; Tufano M; D'Arrigo P; Vigorito V; Russo S; Romano MF
    Semin Cancer Biol; 2020 Feb; 60():181-190. PubMed ID: 31422157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
    Frediani JN; Fabbri M
    Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    Chockley PJ; Chen J; Chen G; Beer DG; Standiford TJ; Keshamouni VG
    J Clin Invest; 2018 Apr; 128(4):1384-1396. PubMed ID: 29324443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the role of EMT in tumor immune escape.
    Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
    Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.